MINIREVIEWS

1. Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae: Etiology and antibiotic treatment
2. Molecular heterogeneity in intrahepatic cholangiocarcinoma
3. Spectrum of esophageal motility disorders in patients with liver cirrhosis
4. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
5. Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far

ORIGINAL ARTICLE

1. Cyclin-dependent kinase inhibitors p21 and p27 function as critical regulators of liver regeneration following 90% hepatectomy in the rat
2. Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma
3. Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
4. Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature
5. Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
6. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis
7. Bioelectrical impedance vector analysis evaluates cellularity and hydration in cirrhotic patients
8. Incidental biliary dilation in the era of the opiate epidemic: High prevalence of biliary dilation in opiate users evaluated in the Emergency Department
9. Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis
10. HIPPOCRATES® project: A proof of concept of a collaborative program for hepatitis C virus microelimination in a prison setting
11. Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

CASE REPORT

1. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in postliver transplant patients with previous direct-acting antiviral failure:Six case reports
2. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report
3. Hepatitis E virus re-infection accelerates hepatocellular carcinoma development and relapse in a patient with liver cirrhosis: A case report and review of literature

LETTER TO THE EDITOR

1. Autophagy related protein 9A increase in hepatitis B virusassociated hepatocellular carcinoma and the role in apoptosis